Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.057 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |